Nektar Therapeutics | NKTR - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
ALKERMES USD 142.86M 40.5M 2026-06
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amgen USD 2.86B 16.65B 2026-06
Baxter International USD 1.03B 52M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
Biogen USD 403.9M 45.4M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Cara Therapeutics USD 4.62M 1.4M 2026-03
Cipla INR 32.3B 1.95B 2026-03
Dr.Reddys Laboratories INR 37.5B 7.12B 2026-06
Eisai JPY 87.53B 11.64B 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Exelixis USD 39.06M 14.91M 2026-06
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Incyte USD 1.39B 1.16B 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
Karyopharm Therapeutics USD 4.28M 276K 2026-03
MacroGenics USD 3.44M 845K 2026-06
Merck USD 3.83B 36M 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.26B 64M 2026-06
Pfizer USD 4.58B 75M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Takeda JPY 446.78B 44.56B 2026-06
Teva Pharmaceutical Industries USD 2.72B 125M 2026-06
Xencor USD 12.65M 4.73M 2026-06